Liver ergothioneine accumulation in a guinea pig model of non-alcoholic fatty liver disease. A possible mechanism of defence?
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
L-ergothioneine (ET), a putative antioxidant compound acquired by animals through dietary sources, has been suggested to accumulate in certain cells and tissues in the body that are predisposed to high oxidative stress. In the present study, we identified an elevation of ET in the liver of a guinea pig model of non-alcoholic fatty liver disease (NAFLD), elucidated a possible mechanism for the increased uptake and investigated the possible role for this accumulation. This increase in liver ET levels correlated with cholesterol accumulation and disease severity. We identified an increase in the transcriptional factor, RUNX1, which has been shown to upregulate the expression of the ET-specific transporter OCTN1, and could consequently lead to the observable elevation in ET. An increase was also seen in heat shock protein 70 (HSP70) which seemingly corresponds to ET elevation. No significant increase was observed in oxidative damage markers, F2-isoprostanes, and protein carbonyls, which could possibly be attributed to the increase in liver ET through direct antioxidant action, induction of HSP70, or by chelation of Fe(2+), preventing redox chemistry. The data suggest a novel mechanism by which the guinea pig fatty liver accumulates ET via upregulation of its transporter, as a possible stress response by the damaged liver to further suppress oxidative damage and delay tissue injury. Similar events may happen in other animal models of disease, and researchers should be aware of the possibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Epidemiology of Non-Alcoholic Fatty Liver Disease
Bellentani, S., Scaglioni, F., Marino, M., & Bedogni, G. (2010) · Digestive Diseases · doi:10.1159/000282080 · Cited by 1,026 · cited 1×
“most common causes of chronic liver disease [7].”
BackgroundErgothioneine; antioxidant potential, physiological function and role in disease
Cheah, I. K., & Halliwell, B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.09.017 · Cited by 514
Self-citationThe isoprostanes—25 years later
Milne, G. L., Dai, Q., & Roberts, L. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.10.007 · Cited by 335 · cited 1×
“Strangely, despite the advanced liver damage, no significant increase in hepatic lipid peroxidation was detected using F2-isoprostanes (F2-IsoPs; probably the most reliable biomarker marker of lipid peroxidation [21,22]), nor was there a rise in protein carbonyls, a commonly used biomarker of oxidative protein damage…”
BackgroundThe antioxidant action of ergothioneine
Akanmu, D., Cecchini, R., Aruoma, O. I., & Halliwell, B. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90158-f · Cited by 251 · cited 1×
“Numerous in vitro and a handful of in vivo studies have demonstrated the potentially beneficial properties of ET, in neurodegeneration [43,44] and cardiovascular disorders [45,46] and as an antioxidant [2,36,47], a metal chelator [4,5], and an anti-inflammatory agent [48,49].”
BackgroundSelf-citationFacchini, F. S., Hua, N. W., & Stoohs, R. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.32403 · Cited by 233 · cited 1×
“Studies have shown that iron depletion can reduce serum alanine aminotransferase (a marker of liver damage) and blood insulin in NAFLD patients [16].”
BackgroundPrevalence of Body Iron Excess in the Metabolic Syndrome
Bozzini, C., Girelli, D., Olivieri, O., Martinelli, N., Bassi, A., De Matteis, G., Tenuti, I., Lotto, V., Friso, S., Pizzolo, F., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2061 · Cited by 224 · cited 1×
“abnormalities associated with risk of NAFLD [13,14] and”
BackgroundGene Knockout and Metabolome Analysis of Carnitine/Organic Cation Transporter OCTN1
Kato, Y., Kubo, Y., Iwata, D., Kato, S., Sudo, T., Sugiura, T., Kagaya, T., Wakayama, T., Hirayama, A., Sugimoto, M., et al. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0076-z · Cited by 206 · cited 1×
“be highly specific and facilitated only by OCTN1 [29],”
BackgroundWrede, C. E., Buettner, R., Bollheimer, L. C., Schölmerich, J., Palitzsch, K.-D., & Hellerbrand, C. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02083 · Cited by 161 · cited 1×
“abnormalities associated with risk of NAFLD [13,14] and”
BackgroundErgothioneine protects against neuronal injury induced by β-amyloid in mice
Yang, N.-C., Lin, H.-C., Wu, J.-H., Ou, H.-C., Chai, Y.-C., Tseng, C.-Y., Liao, J.-W., & Song, T.-Y. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.08.021 · Cited by 123
Cited by
Ergothioneine – a diet‐derived antioxidant with therapeutic potential
Halliwell, B., Cheah, I. K., & Tang, R. M. Y. (2018) · FEBS Letters · doi:10.1002/1873-3468.13123 · Cited by 305
Self-citationThe biology of ergothioneine, an antioxidant nutraceutical
Borodina, I., Kenny, L. C., McCarthy, C. M., Paramasivan, K., Pretorius, E., Roberts, T. J., van der Hoek, S. A., & Kell, D. B. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422419000301 · Cited by 296
“liver disease(476), massively so in mouse models of myocardial”
BackgroundCheah, I. K., Tang, R. M. Y., Yew, T. S. Z., Lim, K. H. C., & Halliwell, B. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6778 · Cited by 196
“The selective expression of slc22a4 (encoding the ET transporter, OCTN1) and the consequential presence of ET in organs and cells that are prone to oxidative stress and inflammation further hint at a possible cytoprotective physiological role for ET (12, 25).”
Self-citationDistribution and accumulation of dietary ergothioneine and its metabolites in mouse tissues
Tang, R. M. Y., Cheah, I. K.-M., Yew, T. S. K., & Halliwell, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-20021-z · Cited by 163
Self-citationErgothioneine, an adaptive antioxidant for the protection of injured tissues? A hypothesis
Halliwell, B., Cheah, I. K., & Drum, C. L. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.12.124 · Cited by 123
Self-citation
Metadata
- Authors
- Cheah, I. K., Tang, R., Ye, P., Yew, T. S. Z., Lim, K. H. C., & Halliwell, B.
- Venue
- Free Radical Research
- Publisher
- Informa UK Limited
- Published
- 2015-12-04
- Volume
- 50
- Issue
- 1
- Pages
- 14-25
- ISSN
- 1029-2470 (ISSN-L)
- 1071-5762
- OpenAlex
- W2186296695
- Cited by
- 70
- References
- 16
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Liver ergothioneine accumulation in a guinea pig model of non-alcoholic fatty liver disease. A possible mechanism of defence? https://app.cochat.ai/papers/10.3109/10715762.2015.1099642
- The paper
- Cheah, I. K., Tang, R., Ye, P., Yew, T. S. Z., Lim, K. H. C., & Halliwell, B. (2016). Liver ergothioneine accumulation in a guinea pig model of non-alcoholic fatty liver disease. A possible mechanism of defence? Free Radical Research. https://doi.org/10.3109/10715762.2015.1099642
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.